Penta Investments plans to acquire Mediq Apteka pharmacies, positioning Dr. Max as the second largest pharmacy chain in Poland.
Information on the Target
Penta Investments (Penta) is poised to acquire pharmacies operated by the ACP Pharma group, known as Mediq Apteka. This acquisition is part of ACP Pharma S.A.'s divestment strategy, with Penta collaborating closely with Neuca S.A. Once the deal is finalized, Penta's pharmacy operations will rank as the second largest in Poland, encompassing approximately 300 pharmacies.
The transaction is currently pending approval from the Office of Competition and Consumer Protection.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Poland
The pharmacy sector in Poland has experienced significant growth in recent years, driven by an increasing demand for health care services and a rising
Similar Deals
General Atlantic → Balaji Wafers
2026
Penta Investments
invested in
Mediq Apteka
in 2023
in a Strategic Partnership deal
Disclosed details
Revenue: $140M